| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $326.7M | $202.7M | $144.0M |
| YoY Revenue Growth % | +61.2% | +40.8% | — |
| Gross Profit | $175.0M | $104.5M | — |
| Gross Margin % | 53.6% | 51.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$67.0M | -$115.2M | -$107.2M |
| Operating Margin % | -20.5% | -56.9% | -74.4% |
| Net Income (GAAP) | -$42.9M | -$93.6M | -$80.5M |
| EBITDA (Normalized) | -$25.4M | -$86.3M | -$102.0M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $87.2M | $23.2M | $8.1M |
| Capital Expenditures (CapEx) | $52.0M | $36.2M | $6.5M |
| Free Cash Flow (FCF) | $35.1M | -$13.0M | $1.6M |
| FCF Margin % | 10.8% | -6.4% | 1.1% |
| Return on Invested Capital (ROIC %) | -4.9% | -13.3% | -1.7% |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $62.3M | $83.4M | $1.89B |
| Total Stockholders' Equity | $1.16B | $699.7M | $3.87B |